Search details
1.
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Br J Haematol
; 2024 May 27.
Article
in English
| MEDLINE | ID: mdl-38802107
2.
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.
Oncologist
; 28(9): 799-803, 2023 09 07.
Article
in English
| MEDLINE | ID: mdl-37226534
3.
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group.
BMC Med Res Methodol
; 23(1): 179, 2023 08 03.
Article
in English
| MEDLINE | ID: mdl-37537545
4.
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6.
Support Care Cancer
; 31(5): 256, 2023 Apr 12.
Article
in English
| MEDLINE | ID: mdl-37043087
5.
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Eur J Haematol
; 107(3): 333-342, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34053112
6.
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial.
Am J Hematol
; 96(5): 552-560, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-33650179
7.
Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes.
Clin Trials
; 16(1): 14-17, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30466310
8.
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12.
Blood
; 126(6): 733-8, 2015 Aug 06.
Article
in English
| MEDLINE | ID: mdl-26109202
9.
Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study.
Can J Diabetes
; 48(3): 195-203.e1, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38211830
10.
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice.
Leuk Lymphoma
; 65(5): 609-617, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38235709
11.
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma.
Blood
; 128(5): 732-5, 2016 08 04.
Article
in English
| MEDLINE | ID: mdl-27338095
12.
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
Am J Hematol
; 93(2): E49-E52, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29164656
13.
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities.
BMJ Open
; 13(8): e073353, 2023 08 11.
Article
in English
| MEDLINE | ID: mdl-37567744
14.
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 23(7): 484-490, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37127473
15.
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.
J Clin Oncol
; 41(25): 4164-4177, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37319384
16.
Relapse timing is associated with distinct evolutionary dynamics in DLBCL.
medRxiv
; 2023 Mar 08.
Article
in English
| MEDLINE | ID: mdl-36945587
17.
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials.
Curr Oncol
; 28(2): 1518-1527, 2021 04 13.
Article
in English
| MEDLINE | ID: mdl-33924380
18.
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial.
Curr Oncol
; 28(2): 1256-1261, 2021 03 17.
Article
in English
| MEDLINE | ID: mdl-33802634
19.
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data.
Curr Oncol
; 28(2): 1153-1160, 2021 03 08.
Article
in English
| MEDLINE | ID: mdl-33800281
20.
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience.
J Natl Cancer Inst
; 113(10): 1422-1428, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-33760057